Deciphering the modulatory role of apigenin targeting oncogenic pathways in human cancers

Area of Science:

• Oncology
• Natural Product Chemistry
• Molecular Biology

Background:

• Cancer involves complex intrinsic and extrinsic pathways, driving research into natural extracts for treatments with fewer side effects.
• Natural product-derived compounds are increasingly investigated for their chemotherapeutic potential.
• Apigenin, a flavonoid found in plants, has demonstrated promising anticancer properties in various studies.

Purpose of the Study:

• To provide detailed insights into the anticancer potential of apigenin.
• To elucidate how apigenin modulates numerous cell signaling pathways for cancer treatment.
• To summarize apigenin-mediated modulation of oncogenic pathways in various malignancies.

Main Methods:

• Review of experimental and biological studies on apigenin's anticancer effects.
• Analysis of apigenin's role in modulating cell signaling pathways.
• Focus on apigenin's impact on oncogenic pathways across diverse human tumors.

Main Results:

• Apigenin induces cell growth arrest and apoptosis in a wide range of human cancers.
• Apigenin modulates multiple cell signaling pathways involved in cancer progression.
• Evidence suggests apigenin's efficacy against breast, lung, liver, skin, blood, colon, prostate, pancreatic, cervical, oral, and stomach cancers.

Conclusions:

• Apigenin exhibits significant anticancerous potential through the modulation of various cell signaling pathways.
• Apigenin's ability to induce cell growth arrest and apoptosis makes it a potential therapeutic alternative.
• Further research into apigenin-mediated pathway modulation could lead to novel cancer treatments.